business

SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand

Investing.com · May 13, 2026, 6:21 AM · Also reported by 2 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Under Armour (UAA) Shares Sink After Earnings Miss and Weak FY2027 Guidance CNBC Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand

Also covered by

More in business